What is Drugs Made In America Acquisition II Median PS Value?
Drugs Made In America Acquisition IIDMII 15 Median PS Value is $0.00 as of Jul. 11, 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 50 Diversified Financial Services companies, Drugs Made In America Acquisition II ranks worse than 1999998% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
DMII's Price-to-Median-PS-Value is not ranked *
in the Diversified Financial Services industry.
Industry Median: 0.915 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Drugs Made In America Acquisition II (NAS:DMII) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Drugs Made In America Acquisition II's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
10.10
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drugs Made In America Acquisition II Median PS Value Related Terms
Drugs Made In America Acquisition II Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drugs Made In America Acquisition II Median PS Value Chart
Drugs Made In America Acquisition II Annual Data
Trend
Dec24
Dec25
Median PS Value
0.00
0.00
Drugs Made In America Acquisition II Quarterly Data
DMII vs BCSS, EVAC, CEPF: Median PS Value Comparison
For the Shell Companies subindustry, Drugs Made In America Acquisition II's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Drugs Made In America Acquisition II Price-to-Median-PS-Value vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition II's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Drugs Made In America Acquisition II's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is .
Drugs Made In America Acquisition II's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drugs Made In America Acquisition II (DMII) has a Median PS Value of $0.00 as of Jul. 11, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Drugs Made In America Acquisition II and its competitors. According to the industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 50 companies in the Diversified Financial Services industry.
Is Drugs Made In America Acquisition II's Median PS Value too high?
Drugs Made In America Acquisition II's current Median PS Value is $0.00. Based on the distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 50 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Median PS Value compare to BCSS and EVAC?
According to the Diversified Financial Services industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 50 companies for Median PS Value. This places Drugs Made In America Acquisition II in the lower half of its industry. The industry median Median PS Value is 0.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Diversified Financial Services company?
The median Median PS Value among Diversified Financial Services companies is 0.92, based on 50 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Drugs Made In America Acquisition II and its competitors. For the Diversified Financial Services industry, the median Median PS Value is 0.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Drugs Made In America Acquisition II's current Median PS Value is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Median PS Value of $0.00. The current Median PS Value is $0.00. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Median PS Value is $0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Drugs Made In America Acquisition II Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMII has been successfully added to your 